跳至主要内容
临床试验/NL-OMON28896
NL-OMON28896已完成不适用

Thrombelastography-based application of fibrinogen therapy for massive blood loss during elective surgery for craniosynostosis repair, a double blinded randomized controlled study.

Erasmus MCDr. Molewaterplein 603015 GJ Rotterdamthe Netherlands0 个研究点目标入组 114 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
114

研究概览

简要总结

/A

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Primary non-syndromic craniosynostosis undergoing elective repair from September 2011;
  • 2. Written informed consent;

排除标准

  • 1. The presence of congenital bleeding diathesis or congenital prothrombotic risk factors like proteine C or S deficiency or antithrombin deficiency. (Congenital Factor F Leiden and the prothrombin F II mutation are no contraindication for surgery);
  • 2. Known hypersensitivity against Haemocomplettan P®;

研究者

发起方
Erasmus MCDr. Molewaterplein 603015 GJ Rotterdamthe Netherlands

相似试验

TEG based application of fibrinogen in children. | 临床试验